Compounds > alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol
Page last updated: 2024-09-02

alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and ritanserin

alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol has been researched along with ritanserin in 1 studies

Compound Research Comparison

Studies
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)		Trials
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)		Recent Studies (post-2010)
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)		Studies
(ritanserin)		Trials
(ritanserin)		Recent Studies (post-2010) (ritanserin)
90127357571

Protein Interaction Comparison

ProteinTaxonomyalpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol (IC50)ritanserin (IC50)
5-hydroxytryptamine receptor 2CRattus norvegicus (Norway rat)0.0012
5-hydroxytryptamine receptor 2ARattus norvegicus (Norway rat)0.001
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)0.047
Diacylglycerol kinase alphaHomo sapiens (human)9
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)0.047
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.0025
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.0025
5-hydroxytryptamine receptor 2BRattus norvegicus (Norway rat)0.0012
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.0025
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.047
D(2) dopamine receptorRattus norvegicus (Norway rat)0.012

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Araki, H; Ogawa, S; Okuyama, S; Otomo, S1

Other Studies

1 other study(ies) available for alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and ritanserin

ArticleYear
Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced cognitive dysfunction.
    European journal of pharmacology, 1994, Sep-22, Volume: 263, Issue:1-2

    Topics: Animals; Anisoles; Anti-Anxiety Agents; Cognition Disorders; Drug Interactions; Ligands; Male; Phencyclidine; Physical Exertion; Piperidines; Propylamines; Pyrimidines; Rats; Rats, Wistar; Receptors, sigma; Ritanserin; Swimming

1994